About Us

HD Insights is a semiannual publication that highlights the latest research on Huntington’s disease. We provide our readers with information about the most recent scientific findings and clinical trials that are underway, and we introduce them to the individuals and companies who are working diligently to pursue therapies and even a cure for HD.

HD Insights wouldn’t be possible without the following people:

Publication Staff

Daniel Claassen, M.D. — Editor-in-Chief, Vanderbilt University Medical Center

Margy Rockwood — Deputy Editor

Lise Munsie, Ph.D. — Scientific Content Reviewer

Emma Berkner — Assistant Editor and Web Master

Christina Ullman, MSJ — Art Director

Huntington Study Group

Shari Kinel, J.D. — Chief Executive Officer

Andrew Feigin, M.D. — Chief Medical Officer

Elise Kayson, M.S., ANP — Vice President of Clinical Operations

Christopher A. Ross, M.D., Ph.D. — Chief Scientific Officer

Anne Van Dusen, CHC — Chief Operating Officer

Brett Kinsler, D.C. — Chief Innovation Officer

Michael Lentine, MBA – Chief Financial Officer

Samuel Frank, M.D. — Co-Chair of EMC

Sandra Kostyk, M.D., Ph.D. — Co-Chair of EMC